Presentation first given at the Digital Health Summit Turkey, Istanbul, 11 – 12 September 2012. This was the first event of its type in Turkey with representatives of all major healthcare stakeholders: HCPs, patients, pharma, payers, government, academia, regulators, digital agencies and the media. Some 200 delegates participated.
http://www.ptms.com.tr/
Multichannel Pharma Marketing by Wiley InterfaceWiley Asia
Are you maximizing your reach to physicians?
Today’s physicians get medical information via multiple channels – conferences, peer-reviewed journals, your communications both online and offline. Find out how you can determine the right channel mix for your physicians to communicate your brand’s message effectively.
Watch our video to learn more and apply multichannel marketing in practice to boost 10% growth.
Engaging hcp and patients through a Multichannel campaign - eyeforpharma Ista...Sven Awege
Pharma context
Dozens of channels (for HCP & the rest of us)
Channel coverage - today and tomorrow
…and then there’s the sticky question on messages & channels?
…not forgetting compliance & privacy..
…Medical & Regulatory…
..human resistance to change…
…and infrastructure capabilities!
And then there’s that wierd thing happening in social media and mobile devices
Summary:
The concept of closed-loop real-time multi-channel marketing is great, but…
Start with baby steps to learn how to run
Use common sense, ROI calculations are probably impossible to prove and will distract us from focusing on what matters
Absolute clarity on objectives and how to measure results
Key Learnings:
Estimate time necessary then triple it
Validate your objectives (MR, focus groups)
Focus on fewer channels but execute with excellence
Channel selection:
Suitability for objective, Reach, impact, CPI
Internal marketing & educating
Establish processes, R&R
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
Personalized HCP Marketing: How to Create More Impactful Brand ExperiencesMerkle
At this year's ePharma 2015 Conference, Croom Lawrence, Senior Director, Digital, Merkle Health, shared the importance of personalization for healthcare consumers and physicians. In his presentation, Croom discussed how an Addressable Customer Experience strategy can create more impactful brand experiences.
Multichannel Pharma Marketing by Wiley InterfaceWiley Asia
Are you maximizing your reach to physicians?
Today’s physicians get medical information via multiple channels – conferences, peer-reviewed journals, your communications both online and offline. Find out how you can determine the right channel mix for your physicians to communicate your brand’s message effectively.
Watch our video to learn more and apply multichannel marketing in practice to boost 10% growth.
Engaging hcp and patients through a Multichannel campaign - eyeforpharma Ista...Sven Awege
Pharma context
Dozens of channels (for HCP & the rest of us)
Channel coverage - today and tomorrow
…and then there’s the sticky question on messages & channels?
…not forgetting compliance & privacy..
…Medical & Regulatory…
..human resistance to change…
…and infrastructure capabilities!
And then there’s that wierd thing happening in social media and mobile devices
Summary:
The concept of closed-loop real-time multi-channel marketing is great, but…
Start with baby steps to learn how to run
Use common sense, ROI calculations are probably impossible to prove and will distract us from focusing on what matters
Absolute clarity on objectives and how to measure results
Key Learnings:
Estimate time necessary then triple it
Validate your objectives (MR, focus groups)
Focus on fewer channels but execute with excellence
Channel selection:
Suitability for objective, Reach, impact, CPI
Internal marketing & educating
Establish processes, R&R
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
Personalized HCP Marketing: How to Create More Impactful Brand ExperiencesMerkle
At this year's ePharma 2015 Conference, Croom Lawrence, Senior Director, Digital, Merkle Health, shared the importance of personalization for healthcare consumers and physicians. In his presentation, Croom discussed how an Addressable Customer Experience strategy can create more impactful brand experiences.
Engage like Amazon: omnichannel HCPs engagement for pharma marketingViseven
The popularity of omnichannel approach is growing across all markets and regions, leaving multichannel behind. Giants like Amazon, Disney, and Starbucks have already built their own omnichannel digital marketing strategies. Unveil the difference between multichannel and omnichannel engagement in pharma marketing and choose the best way to launch your next HCPs engagement campaign.
Contact Viseven to build the efficient multi/omnichannel strategy: https://viseven.com/contact-us
https://viseven.com/
Subscribe to youtube channel https://bit.ly/38owdcN
7 P's of Digital Pharma Marketing by Tughan DemirbilekTughan Demirbilek
About the 7 P’s of Digital Pharma Marketing
The 7P’s of Digital Pharma Marketing is a summary of some important things I’ve learned over years in practice. I hope you find them useful. Please feel free to share with others and contribute your own learnings and experiences.
About me
I am a designer, a strategist and a marketeer.
I’ve been in pharma marketing for over 15 years and have been working on digital marketing projects for over 10.
I’ve worked for Pfizer, IMS Health, Herbalife and BMS in local and regional roles.
I studied architecture in Istanbul and business in London, and I reinvent my career every ten years.
PS: The 7P’s originally started as a training slide set of 5 topics and evolved to 7 over time. And yes, 7P’s is probably easier to remember than 4P’s 2T’s and 1S or something like that.
You may email me at tughan777@gmail.com or follow me on Twitter @tughan777
Customer Experience (CX) in Physician and HCP EngagementMarketResearch.com
Customer Experience Management: What are the essential ingredients for delivering a successful CX programme?
All in it together? There is a tendency for pharma to think in silos - how can this be challenged to deliver coherent company-wide customer communications?
Same goal, different needs: How can pharma meet the differing content and communication preferences of physicians and other healthcare professionals?
Something different: How will high levels of customer satisfaction differentiate your product in a crowded market place and encourage wider use?
Getting it wrong: Why do so many digital initiatives fail to engage physicians and HCPs?
Wider support: How can stakeholders work with pharma to create a mutually beneficial customer experience?
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Many pharmaceutical companies face the same pain points when it comes to designing, implementing and employing CLM digital platforms. In this whitepaper we explore the challenges CLM poses for the pharma industry and how digital providers and their solutions need to address these pain points.
The New Rules Of Doctor Engagement in the New Normal
2020, which could very well be the year of the coronavirus, has been witnessing drastic disruptions with enforced lockdowns, social distancing, new patient demands and healthcare systems put under extraordinary pressures. The pandemic has worsened the pharma market in India and is expected to lead the country towards a major slowdown.
Challenges that have arised
> Doctors not ready to meet MRs
> No physical events possible
> Virtual events doesn't give FaceTime with doctors
#DIGITALMARKETING #PHARMAMARKETING #DOCTORMARKETING #HOSPITALMARKETING #HEALTHCAREMARKETING #RELEVANTINTERACTIONS
B2B buyers are increasingly influenced by social, mobile, and other digital channels. This presentation shows why B2B companies should adopt digital strategies in order to nurture leads along the buyer path and enable dialogue for their sales teams.
4 success factors for pharma multichannel marketingCOUCH Health
While planning is important, it’s the implementation of your pharma multichannel marketing strategy that determines the success of your efforts. To get this right, you’ll need to apply marketing fundamentals and business best practices to the integrated-channel solutions at your disposal. The critical success factors for effective implementation are outlined in this presentation.
The purpose of this two-day workshop was to help marketers build successful multichannel strategies that connect with customers in increasingly meaningful ways across discreet yet interconnected channels. Specifically it focuses on how to: 1) develop a 360 view of customers to inform a channel architecture strategy, 2) deliver personally relevant information through a compelling content and contact strategy, 3) align channels through brand strategy to create a cohesive user experience, 4) integrate measurement across channels for business performance enhancement, and 5) create internal infrastructure and readiness systems that equip organizations to coordinate effective responses to customer needs.
Engage like Amazon: omnichannel HCPs engagement for pharma marketingViseven
The popularity of omnichannel approach is growing across all markets and regions, leaving multichannel behind. Giants like Amazon, Disney, and Starbucks have already built their own omnichannel digital marketing strategies. Unveil the difference between multichannel and omnichannel engagement in pharma marketing and choose the best way to launch your next HCPs engagement campaign.
Contact Viseven to build the efficient multi/omnichannel strategy: https://viseven.com/contact-us
https://viseven.com/
Subscribe to youtube channel https://bit.ly/38owdcN
7 P's of Digital Pharma Marketing by Tughan DemirbilekTughan Demirbilek
About the 7 P’s of Digital Pharma Marketing
The 7P’s of Digital Pharma Marketing is a summary of some important things I’ve learned over years in practice. I hope you find them useful. Please feel free to share with others and contribute your own learnings and experiences.
About me
I am a designer, a strategist and a marketeer.
I’ve been in pharma marketing for over 15 years and have been working on digital marketing projects for over 10.
I’ve worked for Pfizer, IMS Health, Herbalife and BMS in local and regional roles.
I studied architecture in Istanbul and business in London, and I reinvent my career every ten years.
PS: The 7P’s originally started as a training slide set of 5 topics and evolved to 7 over time. And yes, 7P’s is probably easier to remember than 4P’s 2T’s and 1S or something like that.
You may email me at tughan777@gmail.com or follow me on Twitter @tughan777
Customer Experience (CX) in Physician and HCP EngagementMarketResearch.com
Customer Experience Management: What are the essential ingredients for delivering a successful CX programme?
All in it together? There is a tendency for pharma to think in silos - how can this be challenged to deliver coherent company-wide customer communications?
Same goal, different needs: How can pharma meet the differing content and communication preferences of physicians and other healthcare professionals?
Something different: How will high levels of customer satisfaction differentiate your product in a crowded market place and encourage wider use?
Getting it wrong: Why do so many digital initiatives fail to engage physicians and HCPs?
Wider support: How can stakeholders work with pharma to create a mutually beneficial customer experience?
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
E-Marketing in the Pharmaceutical Industry (a student presentation)SunnyShah
As a way of giving back to our university, The University of the Sciences in Philadelphia, Dominic, Rina, and myself gave a presentation about "e-Marketing in the Pharmaceutical Industry".
All points taken from this presentation were only used by students for educational purposes and much of the information was gathered from the 8th annual ePharma Summit that we went to.
Many pharmaceutical companies face the same pain points when it comes to designing, implementing and employing CLM digital platforms. In this whitepaper we explore the challenges CLM poses for the pharma industry and how digital providers and their solutions need to address these pain points.
The New Rules Of Doctor Engagement in the New Normal
2020, which could very well be the year of the coronavirus, has been witnessing drastic disruptions with enforced lockdowns, social distancing, new patient demands and healthcare systems put under extraordinary pressures. The pandemic has worsened the pharma market in India and is expected to lead the country towards a major slowdown.
Challenges that have arised
> Doctors not ready to meet MRs
> No physical events possible
> Virtual events doesn't give FaceTime with doctors
#DIGITALMARKETING #PHARMAMARKETING #DOCTORMARKETING #HOSPITALMARKETING #HEALTHCAREMARKETING #RELEVANTINTERACTIONS
B2B buyers are increasingly influenced by social, mobile, and other digital channels. This presentation shows why B2B companies should adopt digital strategies in order to nurture leads along the buyer path and enable dialogue for their sales teams.
4 success factors for pharma multichannel marketingCOUCH Health
While planning is important, it’s the implementation of your pharma multichannel marketing strategy that determines the success of your efforts. To get this right, you’ll need to apply marketing fundamentals and business best practices to the integrated-channel solutions at your disposal. The critical success factors for effective implementation are outlined in this presentation.
The purpose of this two-day workshop was to help marketers build successful multichannel strategies that connect with customers in increasingly meaningful ways across discreet yet interconnected channels. Specifically it focuses on how to: 1) develop a 360 view of customers to inform a channel architecture strategy, 2) deliver personally relevant information through a compelling content and contact strategy, 3) align channels through brand strategy to create a cohesive user experience, 4) integrate measurement across channels for business performance enhancement, and 5) create internal infrastructure and readiness systems that equip organizations to coordinate effective responses to customer needs.
The Ten Step Guide to Creating Your Multi-Channel Marketing Strategy Netplus
With so many choices, channels and constraints how do you prioritize your budgets and resources to maximize the impact of your interactive marketing?
This webinar will cover how to:
• Get buy in from key stakeholders
• Construct concurrent or consecutive programs so they support and enhance each other
• Prioritize efforts across channels based on what really matters
• Separate test budgets from working budgets
• Develop and execute actionable dashboards
• Deciding which channels make sense for the audience and content
Speakers
Robin Neifield, CEO, NetPlus Marketing
LBi are a leading global marketing and technology agency with over 2,100 employees worldwide and an outstanding CRM centre of excellence based in London.
Once you define your story, it’s time to decide how and where you want to tell it. This chapter gives you several models and frameworks for you to decide how you want to drive your channel strategy.
A keynote presentation I gave at FESPA London 2013, exploring the opportunity for print media to live up to the new media principles of our digital-and-near-virtual marketing and communications world.
Marketing theo định hướng dữ liệu (Data-Driven) và Hệ thống quản trị khách hà...ANTS
Marketing theo định hướng dữ liệu (Data-Driven) và Hệ thống quản trị khách hàng Số (Digital CRM & CEM).
“Marketing theo định hướng dữ liệu và Hệ thống quản trị khách hàng số” - ông Đinh Lê Đạt, Chuyên gia về Dữ liệu lớn, Tập đoàn FPT, Đồng sáng lập & CEO ANTS
"Với vai trò của một Marketer & Salesman trong thời đại Internet & Big Data không khó để nhận ra rằng Digital Marketing đã và đang khai phá ra quy cách chuẩn biến dữ liệu thành giá trị thương mại. Tương lai của Sale & Marketing sẽ hợp nhất các chiến lược riêng lẻ, công nghệ sẽ giúp xác định trạng thái khách hàng đang đứng ở đâu trong toàn bộ tiến trình ra quyết định. Thông tin có thể trợ giúp quá trình chọn lựa nội dung quảng cáo và thông điệp tương ứng cần truyền tải đến với người dùng là gì. Câu trả lời chính là nền tảng Marketing hợp nhất trong tương lai không chỉ xoay quanh Marketer không thôi. Thay vào đó nó phải hướng tới khách hàng (Digital CRM) tại bất cứ nơi đâu họ tiếp xúc với nhãn hiệu dù là trực tuyến hay trong đời sống thực."
ANTS.vn
The new 5 forces for digital brands & businessDavid Carr
Whether you’re a traditional or “born digital/mobile” brand or business these forces are already effecting you. The answer is not a magic bullet “Digital Transformation” or a new silo. It’s business models, people, culture, leadership and change.
Developing Your Omni Channel Strategy in the Digitally Fast-Paced Worldsusanprater
Digital media consumption is rising year over year. We are not spreading out our usage across more devices, we’re actually consuming more. As we think about our customer experience, we often forget that they are not reading every word, are not ready to subscribe, set up an account, download our app. If we want to succeed on a large scale, with prospects who are not engaged, we need to surround them with our message, and make it easy for them to interact with us, however and whenever they choose.
More brands feel they are “lagging behind” in omni-channel – If your omni-channel strategy isn’t among the elite, don’t fret because you are not alone. In a recent study by SPS Commerce over 37% of businesses feel as though they are still exploring their omni-channel options and have not developed a long term strategy.
This presentation will teach you:
1. How to develop your own omni channel strategy
2. How other brands have embraced an omni channel strategy
3. How to leverage your data to create a meaningful customer journey with your brand on the customer’s own terms
Differentiate Between Omni Channel & Multi Channel Customer ExperienceMahindra Comviva
The customer service industry is captured by two trending terms- “omnichannel customer service” and “multi-channel customer service”. Multi-channel customer support refers to the availability of customer service across two or more channels like web, e-mail, social media, apps, calls etc. & the omnichannel customer service strategy refers to a customer engagement strategy which caters to the customers via all available channels of support.
Presentation delivered at the Russian Pharmaceutical Forum, St Petersburg, 17 - 19 June 2014, an update of a presentation first delivered in 2012: 'Making sense of multichannel'. The focus is on the progress of pharma multichannel marketing during the period 2012 to 2014, highlighting frequently cited hurdles, significant common practices, and emerging trends.
A review of a decade of European pharmaceuticals online marketing and sales. Presented at EyeforPharma's first European Online Marketing and E-Detailing conference, Berlin, May, 2006
Introductory presentation to an EphMRA Masterclass workshop follow-up webinar given 6 December 2012. The original Masterclass workshop was delivered in Paris June 2012 at the EphMRA '360 Future' conference.
The full recorded webinar will be made available to EphMRA members later in 2013
You cannot rely on intuition and experience alone to make critical marketing investments. Data can help us optimize our marketing efforts, predict results, justify spend and validate our impact and influence on revenue. But to do that, you need to have the right data.
This webinar discusses how to capture the metrics you need and use them to make decisions that will deliver significant performance gains.
Covered in this presentation:
1. Key metrics every B2B marketer must focus on
2. A framework for setting up a solid data foundation
3. The difference between data and insights
4. When and how to act on data-driven insights
At Indegene, with our digital-first approach, we bring agility and innovation to your launch strategy. We enable optimization of channels, content mix and foster continuous learning by adopting an agile operating model that supports cross-functional collaboration and enables launch teams to rapidly create campaigns to address shifting customer needs. With our AI-driven launch model, from strategy to execution, we help you achieve true ‘Launch Excellence’.
At Indegene, with our digital-first approach, we bring agility and innovation to your launch strategy. We enable optimization of channels, content mix and foster continuous learning by adopting an agile operating model that supports cross-functional collaboration and enables launch teams to rapidly create campaigns to address shifting customer needs. With our AI-driven launch model, from strategy to execution, we help you achieve true ‘Launch Excellence’.
The competitive landscape for Email Service Providers (ESPs) has undergone significant change. Sure – marketers more than ever understand the need to invest with an ESP, as tools to boost email communication, targeting and tracking have become essential. However, with 90%+ of the U.S. owning cell phones and 90%+ of cell phone owners keeping their mobile within arms' reach 24/7, the digital world has shifted off of people's desktops and into their pockets. Moreover, email's non-optimal open and time-to-open rates make it ineffective for two-way and time sensitive communication – both hallmark qualities of mobile communication.
That's what makes integrating SMS mobile messaging so powerful for ESPs. SMS complements email elegantly, providing a direct, interactive and immediate pipeline to consumers. Plus, SMS and email strategy are similar, given the importance of developing a subscriber list mapped to various segmentation data.
During this webinar, we analyzed SMS integration for ESPs, putting specific focus on the keys to be successful.
can-ai-be-used-to-refresh-messaging-more-efficiently-for-pharma-brands.pdfNewristics USA
With the Pharma industry rapidly evolving, brand teams are realizing the need for more frequent message refreshes to stay ahead. But often marketing teams don’t have new clinical data or even customer insights to execute a message refresh. If you have nothing new to say, can you really say it differently enough to make a difference?
The new normal is already here. A 'new' new normal loomsLen Starnes
This presentation is an update to a 2-part review of disrupted medical conferences published on Pharmaphorum March 15th and 16th 2022 .
It reflects recent trends and current disruptive global warnings, events, and threats likely to further impact medical meetings
Disrupted medical conferences: THE BIG PICTURELen Starnes
An in-depth analysis of the impact of covid on medical conferences: lessons learnt 2020-2021; consequences for all major stakeholders 2022; scenarios for 2022 and beyond. A visual abstract presents the full analysis.
Disrupted Medical Conferences: What does it mean for Italian pharmas?Len Starnes
Presentation given during a Merqurio.it webinar 26 March 2021. Outlines the implications of covid-disrupted medical society conferences for the Italian pharma industry and the pharma industry in general: likely conference formats 2021; emerging formats 2022 and beyond; % Italian doctors attending major events; hybrid complexity from a pharma perspective; 4 key pharma survival strategies.
The future of scientific congresses: what can we learn from the medical world?Len Starnes
Keynote presentation given during the November 26 Digital University Day organized by the Delft University of Technology, The Netherlands. Focuses on the transformation of medical society congresses to virtual formats during 2020, highlighting outcomes relevant for academic science and technology events.
شبكات تواصل اجتماعي للأطبّاءتعزيز معايير الرعاية الطبّيّة دعم برامج الرعاية...Len Starnes
عرض تقديمي يقدّم للأطبّاء من منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي يوضّح مكانة شبكات الأطبّاء الاجتماعيّة في العالم وتأثيرها على ممارسة مهنة الطبّ. تركيز خاصّ على إمكانيّات الشبكات الكامنة في منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي، مع التركيز على الفرص التي تقدّمها لدعم برامج الإصلاحات الوطنيّة في مجال الرعاية الطبيّة. دروس ومقارنات من الصين.
Doctors' Social Networks: Boosting standards of medical care. Supporting heal...Len Starnes
Presentation given to doctors from the MENA/GCC region outlining the scale of doctors’ social networks worldwide and their impact on the practice of medicine. Special focus on the potential of networks in the MENA/GCC region, highlighting opportunities they offer to support national healthcare reform programmes. Lessons and parallels from China.
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
Digital disruption: What should patient organizations do to stay ahead?Len Starnes
Extended version of a presentation given at Roche's International Experience Exchange for Patient Organizations conference, Athens, 14 - 15 March, 2018. #IEEPO2018
Will global HCPs networks become communities of choice for rare-disease speci...Len Starnes
Analysis of the role of global HCPs' social networks in the management of rare diseases. Case study of the G-Med global neuroendocrine tumour specialist community
Virtual Conferencing: A Roadmap for PharmaLen Starnes
A pragmatic Roadmap for the pharmaceutical and medtech industries to digitize their conference and events channels. Presentation is a follow-up to an earler deck: 'The Medical Conference is Dead. Long Live the Medical Conference'.
Physicians' Social Networks: A New Tool in Global Health Len Starnes
Presentation first given at the Digital Health Summit Turkey, Istanbul, December 17 2015. Focus of the presentation is the emerging role of physicians' social networks in supporting national health reform programmes and managing pandemic threats.
Emergent hybrid medical society conferences: evidence of disruption; impact o...Len Starnes
Presentation first given at the 2015 Eyeforpharma Barcelona Conference; an update of a presentation given in 2013 on the emergent hybrid medical society physical/virtual conference format. Evidence of conference format disruption is presented based on the 2014 European Society of Cardiology Congress. The impact on the pharma industry is explored.
Going social: why patient organizations cannot ignore social media Len Starnes
Presentation goven at the 7th Annual International Experience Exchange for Patient Organizations, Munich, 3 - 4 March 2015; #IEEPO2015. The event was sponsored by Roche.
Some 300 participants attended representing over 40 patient organizations worldwide. The final day of the meeting was dedicated to social media and how they can help patient organizations achieve their goals
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
1. Making sense of
Multichannel
Len Starnes Digital Health Summit Turkey
Len Starnes Marketing & Sales Sakip Sabanci Museum Istanbul
Head of Digital
General Medicine
Digital healthcare consultant 11 – 12 September 2012
7. What is MCM?
‘A marketing methodology that
uses two or more different media
approaches to reach and influence
a target audience in a single
campaign’
Bill Tyson, CEO Strategic Marketing Plus, USA
8. Why do it?
Each channel reinforces the
other thereby increasing the probability
of a call-to-action being taken
9. Are digital and MCM the
same thing?
No, digital is a toolset that
underpins and supports MCM
Panel session opinion, Digital Pharma West, 2012
12. MCM must evolve*
MCM
Profitable engagement
revenue
growth
Cross-channel
integration
Independence
with integrated
teams
50% other
Channel industries
independence
Most
pharmas
Time
*Adapted from: The Multichannel Maturity Mandate, Forrester Research 2011
13. Reasons companies
fail to evolve
No defined strategy
Incompatible org structure
Disparate tech platforms
Cross-Channel Marketing Report 2012, Econsultancy & Responsys
Based on survey of 650 companies in US, EU, AP
14. Most industries optimistic
% agree + completely agree
Will increase sales
& profitability
77%
Will be crucial for
long-term success 76%
MC customer worth
significantly more 65%
than SC customer
*Forrester Consulting, December 2011:
Results based on responses from 226 global marketing decision makers in 27 industries
16. Brand objectives
Increase sales by x% in 6 months
HCPs target audience
GPs Medical specialists Pharmacists Nurses
Segmentation model
High/med/low prescriber See/No see Attitudinal data
Channel preferences/segment
Stated Opt-in/out Relationship data Market research
17. Sales Direct
Mobile rep mail
HCPs’
Events
SNs
Channel proliferation
One-way Two-way
Tele Call
eD centre
SD
Website eMail
eD
18. Select channels on
cost
External Internal
Historical data based Organizational
on cost to increase Rx effort and expertise
Low Medium High Low Medium High
19. Select channels on
suitability
Email
Simple messaging, calls to action
Self-directed eD
Moderately complex messaging,
interactivity, calls to action
HCPs’ SNs
Complex messaging in context,
P2P engagement, relationship building
20. Optimize mix and sequencing
Message 1 Message 2 Message 3
eD wave 1 eD wave 2 eD wave 3
Discussion 1 Discussion 2 Discussion 3
Month 1 2 3 4 5 6
21. HCPs database
Metrics and KPI
framework
Analytics &
Below reporting dashboard
the surface
Learnings
feedback loop
22. The future of MCM will be based on
predictive modelling
23. Insights driven
Why is it happening?
What will happen next?
What must be done to increase sales?
Segment Channel Message Optimum mix
Month
25. Brand Key objectives
Angiotensin
receptor blocker Protect franchise
Indication in EU markets
Hypertension
Target audience Grow in emerging
High Rx GPs markets
Countries
EU, AP, LA Adapted from a Harte-Hanks case study webinar:
http://www.harte-hanks.com/page/resources_webinars
26. Global Direct
channels mail
Website eMail
Core
eD
waves
SF Banner
tools ads
27. Reported results
Market share retained in EU
Growth achieved in AP, LA
Deployed in 33 markets
New campaign running to 2013
Adapted from a Harte-Hanks case study webinar:
http://www.harte-hanks.com/page/resources_webinars
28. Direct
mail
Brand
Inuvair steroid inhaler eMail
Indication
Asthma Call
Target audience centre
GPs
Country eD
Germany
Presented at Pharma eMarketing Europe, Eyeforpharma, Barcelona 2012
29. 30% sales lift in 4 months
Start
Month
Presented at Pharma eMarketing Europe, Eyeforpharma, Barcelona 2012
30. Sales force + 1
Country Channel Th area Int cost KPIs
UK Self eD GI €47 + 22% sales
D Webinar Onc €73 73% intent to Rx
ES Tele eD Endo €34 51% unprom recall
USA HCP portal Eurol €45 + 8% market share
Courtesy: Blue Latitude, UK
32. Uncomfortable
truth
Marketeers will be highly dependent
on mathematicians, statisticians, and
scientists of all types. With profound
implications for the industry
33. In other words, geeks
‘Qforma is an eclectic
blend of science,
serious maths and
business topped with
deep domain expertise’
36. Adoption in 5 years
‘Yes MCM is more effective, but the
more effective it is the more complex
and costly it becomes. If we are to
speed up the process we need to focus
on change management, on education…’
Lars Bogner
Head Digital Centre of Excellence, Leo Pharma, Denmark
37. Adoption in 10 years
‘…necessitates a complete volte-face for
the traditional one-way comms marketer,
with their mindset wrapped around one-
off iPad-pumped campaigns and non-
meaningful KPI/ROIs for the lifespan of
an annual sales budget or new launch
programme’
Johnathan Reid
Senior Commercial IT Project Manager, Abbot Laboratories, UK
38. Adoption in 10 – 15 years
‘…the reluctance of pharma to
traverse MCM is the overwhelmingly
cerebral undertaking it requires and
the "not currently budgeted" costs to
ensure success’
Richie Bavasso
President Virtual Private Social Networks LLC, USA
39. When will pharma marketing
become de facto multichannel
marketing in Turkey?
41. Sincere thanks to the following for their
help in developing this presentation
• All 226 friends and colleagues who kindly responded
to the Linkedin MCM poll, particularly those who
contributed to the discussion
• Duncan Arbour, Blue Latitude, UK
• Mark Bard, Digital Health Coalition, USA
• Paul Dixey, Bluelight, UK
• Kevin Dunn, The Agency Inside - Harte-Hanks, USA
• Lanre Ibitoye, Eyeforpharma, UK
• Monique Levy, Manhattan Research, USA
• Bryon Main, exlpharma, USA
• David Ormesher, Closerlook, USA